The mechanism of heparanase aggressive phenotype priming is in part due to synergy with the heparan sulfate proteoglycan syndecan-1 to create a niche within the bone marrow microenvironment, further driving myeloma growth and dissemination (12, 13). The gene discussed is SDC1; the disease is plasma cell myeloma.